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Enterococci are common inhabitants of the gastrointestinal tracts of humans and
animals and thanks to their capability to tolerate different environmental conditions
and their high rates of gene transfer, they are able to colonize various ecological
niches, as food matrices. Enterococcus faecalis bacteria are defined as controversial
microorganisms. From one side they are used as food starters, bio-control agents
and probiotics to improve human or animal health. From the other side, in the last
two decades enterococci have emerged as important nosocomial pathogens, because
bearing high-level of resistance to antibiotics and several putative virulence factors. In this
study, the soluble proteome quantitation data (LC-MS/MS) of the food-isolated strain E.
faecalis D27 (dairy-isolate) was compared with the soluble proteome quantitation data
of the pathogenic E. faecalis UW3114 (urinary tract infection isolate) and with the one
of the health promoting strain E. faecalis Symbioflor1, respectively. The comparison of
cytosolic protein expression profiles highlighted statistically significant changes in the
abundance of proteins mainly involved in specific metabolic pathways, nutrient transport,
stress response, and cell wall modulation. Moreover, especially in the dairy isolate and
the clinical isolate, several proteins with potential pathogenic implications were found,
such as serine proteases, von Willebrand factor, serine hydrolase with beta lactamase
activity, efflux transporter, and proteins involved in horizontal gene transfer. The analysis
of the extracellular proteome provided interesting results concerning proteins involved
in bacterial communication, such as pheromones and conjugative elements and also
proteins able to interact with human components. The phenotypic characterization
evaluating (i) biofilm formation (ii) hemolytic activity on blood agar plates (iii) protease
activity (iv) gelatinase (v) antibiotic resistance pattern, enabled us to elucidate the risks
associated with the poor characterized foodborne E. faecalis D27.
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INTRODUCTION
Enterococci are ubiquitous gram-positive bacteria that can
be found in various ecosystems, ranging from soil, surface
waters, plants, the gastrointestinal tract (GIT) of animals and
humans as well as in foods. Enterococci also emerged as
important pathogens, since they are one of the major cause
of both nosocomial and outpatient-associated infections (1),
including clinical manifestations such as urinary tract infections,
endocarditis, primary bacteremia and meningitis (2).
In the last decades, enterococci were widely studied
because they have intrinsic (absence of target, impermeability,
absence of uptake mechanism) and, often, acquired (antibiotic
degrading or modifying enzymes) resistance to antibiotics (3,
4). Generally, intrinsic/natural resistance is chromosomally-
encoded and therefore non-transmissible, whereas acquired
resistance can be plasmid-mediated and hence transmissible by
genetic recombination (5). An increasing number of multidrug
resistant enterococci has been detected as the predominant
microbiota under antibiotic pressure, predisposing hospitalized
patients to severe infections and mortality (6).Some virulence
factors and antibiotic resistances determinants are carried on
mobile genetic elements (MGE) (7), supporting the theory of
enterococci as reservoir for antibiotic resistance determinants
found in pathogens (8, 9). A large number of reports has
focused on the presence or absence of virulence determinants
in enterococcal isolates from different origins (food and living
being) (10, 11). In particular, the higher incidence in clinical
isolated enterococci of genetic elements encoding for virulence
factors indicate that these genes enhance their ability to colonize
humans, increasing the infection level, as suggested by virulence
studies on bacterial mutants in animal models (12).
Within enterococci species, whereas E. faecium harbors more
antibiotic resistance traits, E. faecalis shows a higher potential
for virulence, because it synthesizes many proteins that facilitate
interaction with environmental (both biotic and abiotic) surfaces,
biofilm formation and host colonization (13, 14). Some of these
proteins, such as aggregation substance, cytolysin, enterococcal
surface protein, gelatinase and protease, are considered to be
potential virulence factors (15, 16).
Enterococcus faecalis appears to be typically associated with
the human GIT (17) and it is one of the first lactic acid
bacteria (LAB) to colonize the intestine of the newborn (18). In
healthy human GIT, this bacterium is harmless and present in
low abundance, however it can cause life-threatening infections
during antibiotic-induced dysbiosis (19). E. faecalis is usually
carried by food, due to its widespread distribution in the
environment. In particular it is often isolated from food of animal
origin such as meat (20), milk (21), and cheese (22). Its presence
may indicate a natural contamination during manufacturing
processes, in some cases as a consequence of fecal contamination
caused by poor hygiene (23). Otherwise, E. faecalis is used
as starter culture (24) to carry out fermentative processes,
indeed it plays an important role in cheese ripening and
aroma development. However, some authors have reported the
presence of antimicrobial resistance and virulence determinants
in enterococci found in foods, including cheeses (25, 26).
Therefore, a food contaminating E. faecalis could represent a
possible intermediate vehicle for the transmission of pathogenic
traits. In this case, bacteria could act as vectors for the
dissemination of antibiotic resistance determinants and virulence
factors via the food chain to the consumer, a risk that has so far
been poorly addressed (27–29). Actually, it has been observed
that human gut enterococci are probably acquired from food
since they possess the same antibiotypes and toxinogenic profiles
than cattle-, pig-, and sheep- isolated enterococci (30).
Despite the risks associated to E. faecalis have led to define
these bacteria as controversial (31) they are currently present
not only in fermented food but even used as health supplements
and probiotics by the pharmaceutical industry. Enterococcal
probiotics are usually utilized as “food supplements” in the form
of encapsulated or lyophilized pharmaceutical preparations (32).
This choice is partly motivated by the lower acid resistance
of enterococci compared to lactococci and lactobacilli, that
render them less suitable to survive the gastric pH transit.
These bacteria are thus ingested in high number to achieve
functional or probiotic effects especially for treatment of diseases
such as irritable bowel syndrome, diarrhea, antibiotic associated
diarrhea, or for health improvement such as cholesterol levels
lowering or immune regulation (33, 34).
For all these reasons (possible pathogenicity/virulence
determinants or transferable antibiotic resistance characters), a
careful selection of E. faecalis strains for food supplementation
should be done and a constant monitoring on new food-isolated
enterococcal strains is required to limit the propagation of
virtually harmful microorganism. However, evaluating these
risks only by genome analysis of strains is limiting since gene
function annotation is based just on sequence homologies with
genes present in databanks. Therefore, some evidences should
be validated by functional investigations as well as by studying
bacterial protein profiles and separately analyze sub-proteomes.
In this view, the present study intended to characterize
Enterococcus faecalis D27, isolated from cheese, with the specific
aim to elucidate if this strain harbors pathogenic traits or rather
reveals probiotic features. For this reason, we also examine both
a pathogenic (clinically isolated) and a probiotic strain belonging
to the same species, to understand the similarities and differences
among all the three strains by comparing phenotypic traits,
proteomic, and biochemical profiles.
MATERIALS AND METHODS
Bacterial Strains and Cultured Condition
In this study three strains of Enterococcus faecalis (present in
our collection), with different origin were investigated: D27
(isolated from an artisanal cheese), Symbioflor 1 (commercial
probiotic strain) and UW3114 (clinical isolated strain, bearing
the pathogenicity island of E.faecalis MMH594) (35). All strains
were maintained in BHI medium (Oxoid, Munich, Germany)
at −20◦C in 0.5mL aliquots with 0.5mL 40% v/v glycerol.
For both proteome analyses and phenotypical assays three
biological replicates were performed. Bacterial cultures were
grown in the BHI medium at 37◦C with slight agitation (180
rpm). Culture supernatants (extracellular proteome) and cells
Frontiers in Nutrition | www.frontiersin.org 2 May 2019 | Volume 6 | Article 71
Cirrincione et al. E. faecalis Proteomics and Food Safety
(cytosolic proteome) were recovered by centrifugation (10,000xg,
10min, 4◦C) from the same bacterial culture in the early
stationary growth phase.
Sample Preparation for Proteomic
Analyses
Cytosolic Proteins
The intracellular protein extract was obtained as previously
described by Zühlke et al. (36). Briefly, cell pellet was washed with
TE buffer and lysed by glass beads (diameter: 0.1–0.11mm) using
a Precellys 24 Homogenizator (Peq Lab, Erlangen, Germany).In-
solution digestion of protein extracts with trypsin was done
according to the method described previously (37). Proteins were
dissolved in 50mMTEAB/0.1% RapiGestTM SF (Waters, Milford,
MA, USA), reduced with TCEP (tris-(2-carboxyethyl)phosphine
hydrochloride, Invitrogen, Carlsbad, CA, USA) for 45min at
60◦C and alkylated with iodoacetamide (Sigma, Steinheim,
Germany) for 15min at room temperature. Proteins were
digested with 0.5mg trypsin in a 1:200 ratio (Promega, Madison,
MA, USA) for 6 h under gentle agitation at 37◦C. Desalting
of peptides was achieved using a standard protocol (38).
For absolute quantification, a tryptic digest of yeast alcohol
dehydrogenase (ADH1, Waters, USA) was added into the
samples to final concentration of 50 fmol/µL.
Extracellular Proteins
The extracellular protein extract was obtained as previously
describe by Lassek et al. (39). Briefly, 10% TCA were added to
the cell free supernatant and incubated o/n at 4◦C. Samples were
centrifuged (10,000 x g, 1 h, 4◦C). Protein pellet was washed
with 70% ethanol (in the last step 96% ethanol was used).
After drying using a vacuum centrifuge (Concentrator plus,
Eppendorf) proteins were resuspended in 8M urea/2M thiourea
buffer and centrifuged (16,000 x g, 10min, RT) to recovery the
supernatant. Proteins were separated using a CriterionTM TGXTM
precast gel (4–20%, 12+2 Well Comb, 45 µL, 1mm) (Biorad,
Hercules, CA, USA), fitting with Mini Protean II-Apparatus
(140V for 75min, in glycine running buffer). The digestion
of the extracellular proteins was performed as described by
Lassek et al. (39). Briefly, the excised gel pieces, from SDS-
PAGE, were destained using 50% (v/v) methanol in 100mM
NH4HCO3. Gel pieces were dehydrated and modified trypsin
(sequencing grade, Promega, Fitchburg, WI) was added to a
final ratio of 1:10 (trypsin/sample) in 50mM Tris/HCl, pH 7.5,
and the sample incubated at 37◦C overnight. Peptides were
iteratively extracted from the gel using an ultrasonic bath for
15 min.
The protein concentration of both intracellular and
extracellular extracts was determined using Roti Nanoquant
(Roth, Germany) according to the manufacturer’s instructions.
MS Analysis
Cytosolic Proteins
The separation of the peptide mixture from intracellular proteins
was performed using a nanoACQUITYTM UPLCTM system
(Waters, USA) following the protocol described by Zühlke et al.
(36). The obtained data were searched against a randomized
E. faecalis OG1RF database (NCBI, version 2015-09-01) with
added laboratory contaminants and yeast ADH1 sequence and
sequences from the proteins encoded by the pathogenicity island
of E. faecalis MMH594 (5,490 entries). For positive protein
identification the following criteria had to be met: 1 fragment
ion matched per peptide, 5 fragment ions matched per protein,
1 peptide matched per protein; 2 missed cleavages allowed,
primary digest reagent: trypsin, fixed modification: carbamidom
ethylation C (+57.0215), variable modifications: deamidation
N, Q (+0.9840), oxidation M (+15.9949), pyrrolidonecarboxy
lacid N-TERM (−27.9949). The protein false discovery rate
(FDR) was set to 5%. For the final analyses, only identifications
based on at least two peptides were considered. A protein
had to be identified in at least two out of three technical
replicates per biological replicate. In addition, for the final
analysis protein had to be present in two out of three biological
replicates per time point, which reduced FDR on protein level
to <0.7%.
Extracellular Proteins
Peptide mixtures resulting from in-gel tryptic cleavage
were separated by RP chromatography using an EASY-nLC
(ThermoFisher Scientific, Waltham, USA). Fractionated
peptides were loaded onto the analytical column at a flow rate
of 700 nL min−1 in 100% buffer A (0.1% acetic acid) and
separated using a binary 87-min gradient from 5 to 35% of
buffer B (0.1% acetic acid in acetonitrile) at a constant flow
rate of 300 nL min−1. The EASY-nLC was coupled to an
LTQ Orbitrap mass spectrometer (Thermo Fisher Scientific,
Waltham, MA, USA). After a full survey scan in the Orbitrap
(m/z range from 300 to 2,000, resolution 30,000, lock mass
option-enabled [lock mass 445.120025)] MS/MS experiments
in the LTQ XL were performed for the six most abundant
precursor ions (CID). Unassigned charge states and singly
charged ions were excluded from fragmentation; dynamic
exclusion was enabled after 30 s. For protein identification,
spectra were searched against a database of E. faecalis OG1RF
(NCBI, version 2015-09-01) containing sequences of all
predicted proteins from its genome, including reverse sequences
and sequences of common laboratory contaminants and
sequences from the proteins encoded by the pathogenicity
island of E. faecalis MMH594 (5488 entries). Database searches
using Sorcerer SEQUEST (version v. 27 rev. 11, Thermo
Scientific) and Scaffold 4.4.1 (Proteome Software, Portland,
OR, USA) as well as statistical analysis was done as described
earlier (40).
Quantification Methods for Proteome
Analysis of E. faecalis Strains
Cytosolic Proteins
The protocol that was used for the extraction of cytosolic proteins
does not involve any steps that might lead to loss of proteins
and is compatible with downstream in-solution digestion of
proteins. For this reason, the label-free LC-IMSE approach was
chosen for identification and quantification of proteins to reliably
determine the abundances of cytosolic proteins. In particular,
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the absolute quantitative data were obtained by applying a LC-
IMSE approach in combination with the Hi3 quantification
method (41, 42).
Extracellular Proteins
Extraction of extracellular proteins is based on precipitation
and subsequent solubilization of proteins in a buffer that is not
compatible with in-solution digestion. Therefore, separation by
SDS-PAGE and in-gel digestion of proteins was applied, allowing
to obtain reliable quantitative results based on relative spectral
abundances. Relative quantitative data were obtained using a
label-free LC-MS/MS approach and using normalized spectral
counts (NSAF) for quantification of identified proteins (43). In
this approach, the spectral counts of a protein are divided by its
length and normalized to the sum of spectral counts/length in a
given analysis.
Database Deposition and Graphic
Representation of Data
The mass spectrometry proteomics data have been sent to the
Proteome Xchange Consortium via the PRIDE partner repository
(44) with the dataset identifier PXD011701 for the intracellular
proteins and identifier PXD011660 for the extracellular proteins.
For functional prediction and classification of both cytosolic
and extracellular proteins, the analysis pipeline Prophane was
used (40, 45) and Voronoi treemaps were generated using
Paver (Decodon, Greifswald, Germany; http://www.decodon.
com/paver/). Thanks to the Voronoi treemaps, it is possible to
visualize the bacterial proteome, grouping the proteins according
to their function, sub-function or specific protein name (the
functional prediction is based on TIGRFAMS and Cluster of
orthologous groups (COG).
Phenotypic Analyses
The E. faecalis isolates were analyzed for activity of different
known virulence factors namely, biofilm formation, gelatinase,
protease, and hemolytic activity.
Protease Assay
The assay was performed on the cell-free supernatant as
described by Pessione et al. (16), using Azocasein solution
(1% Azocasein, 50 mMTris-HCl, pH 7.5, 5mM EDTA) instead
of Azoalbumin.
Gelatinase Assay
The assay was performed on the cell-free supernatant as
described by Pessione et al. (16). Briefly, 4ml aliquots of a
solution of 3% (p/v) gelatine in 50mM pH 7.3 Tris-HCl were
distributed in 15ml tubes. At room temperature gelatin solution
appears to be liquid, while at 4◦C it becomes solid. The tubes
were incubated at 4◦C for 1 h to evaluate the ability of solution to
solidify and then incubated at 37◦C to bring it at the liquid state
again. Four hundred microliters of the concentrated bacterial
extracellular extracts were added to the liquid solutions and the
mixtures were incubated 2 h at 37◦C, the optimum for gelatinase
activity. After that, they were incubated overnight at 4◦C to allow
to gelatin to solidify again if gelatinase was not present in the
extracellular extracts.
Hemolytic Assay
Cells from a liquid culture were plated on Columbia Agar base
(Oxoid, Munich, Germany) plates enriched with 5% defibrinated
horse blood (TCS Biosciences, Botolph Claydon, UK). The
hemolytic activity was checked after 48 h examining the cultures
for signs of β-hemolysis (clear zones around colonies), α-
hemolysis (green zones around colonies), γ-hemolysis (no sign
of hemolysis).
Biofilm Formation
In vitro biofilm formation was investigated as described by
Laverede Gomez et al. (35) with slight modification. Bacterial
cells from exponential growth phase were incubated for 48 h at
37◦C in 96-well microliter plates. The planktonic culture was
removed and the biofilm (placed on the bottom of the well)
was washed with PBS and stained with crystal violet solution
(Roth, Karlsruhe, Germany). The absorbance at OD595nmof the
99.8% ethanol used to destain the biofilm was measured. The
biofilm formation was determined as OD600nm/OD595nm (ratio
between culture and destaining solution absorbance).
Determination of Antimicrobial Susceptibility
The three strains were tested for susceptibility to 18 antibiotics,
including different antibiotic classes such as aminoglycosides
and glycopeptides, using the broth microdilution method
according to DIN58940 (46). The following antibiotics
were used: penicillin, ampicillin, gentamycin, streptomycin,
vancomycin, teicoplanin, daptomycin, clindamycin,
erythromycin, ciprofloxacin, moxifloxacin, tetracycline,
tigecycline, rifampicin, linezolid, mupirocin, chloramphenicol,
and trimethoprim/sulfamethoxazole. The test was performed
according to EUCAST breakpoints definitions (v 8.1) or to
ECOFF (epidemiological cut-off) values when no breakpoints
were defined (www.eucast.org). As a quality control, also
the E. faecalis ATCC29212 was tested in this experiment, as
recommended by EUCAST guidelines.
RESULTS
The extracellular and intracellular proteomic profiles of the
food-isolate Enterococcus faecalis D27 (from now referred to as
D27) were compared to the profiles of the probiotic E. faecalis
Symbioflor 1 (from now referred to as Symb1) and the pathogenic
E. faecalis UW3114 (from now referred to as UW3114), in order
to assess the potential risks and benefits associated to the not well-
characterized E. faecalis D27. Phenotypic aspects connected to
virulence/pathogenesis were also investigated.
Gel-free Proteomic Analyses
In order to highlight the proteins directly or partially related to
pathogenicity possible present in each of the three investigated
strains, the (NCBI) database of E. faecalis OG1RF was
used for protein identification. Moreover, to identify proteins
encoded by the pathogenicity island (PAI) of UW3114 the
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database also contained the sequences of the PAI of strain
MH594, since many of the proteins encoded by this PAI
were also found on the PAI of UW3114 (35). Only proteins
present in at least two of the three biological replicates, were
considered for comparative analysis. The proteomic pattern
obtained for the food strain D27, was compared to those of
the probiotic strain Symb1 and the clinical isolate UW3114
separately. This approach allowed to establish: (i) which proteins
are expressed by both matched bacteria but in different
amounts and (ii) which proteins belong to the so called
on/off proteins, that are synthesized by one strain but not by
the other.
In the intracellular compartment of D27, Symb1, and
UW3114 we identified 889, 883, and 860 proteins, respectively
(Tables S1, S2). The classification of intracellular proteins in
functional groups reveals similar profiles among the three
strains (Figure 1), including proteins involved in: (I) protein
synthesis, (II) energy metabolism (III) metabolism (metabolite
transport and energy conversion), (IV) protein fate and (IV)
poorly characterized proteins. The most striking difference is
the presence of the high-abundant protein Gls24-like protein
Ef0055 in strain UW3114, located on the pathogenicity island.
In the secretome we identified 440, 370 and 253 proteins for
D27, Symb1, and UW3114, respectively (Tables S3, S4). Only
proteins with extracellular, cell wall, cell membrane or unknown
sub-localization in the localization prediction by pSortb (version
3.0.2) were considered for the discussion.
Comparison Food/Probiotic
Concerning the cytosolic compartment, 794 shared proteins (88
% of the identified proteins), between D27 and Symb1, were
identified by mass spectrometry analysis (Table S1). Figure 2A
shows a general overview on the different proteins amount in
D27 in comparison to Symb1 (color variation in a scale from
red, abundant in D27 to blue, abundant in Symb1). Quantitative
differences were detected, especially for proteins involved in
metabolism, cell envelope, information storage and processing.
Interestingly, the “poorly characterized” protein area comprises
a high number of significant differentially expressed proteins
(Figure 2A).
The proteins that are more abundant in D27 as compared
to Symb1 are 37 and, among them the conserved protein
UCP028846 (18.27 fold change - OG1RF_11419), tagatose-
biphosphate aldolase (11.95 fold change - OG1RF_10434),
1-phosphofructokinase (7.70 fold change - OG1RF_10431),
exonuclease SbcC (6.88 fold change - OG1RF_12058) and
glycosil hydrolase (6.05 fold change - OG1RF_12425) show the
highest fold change values. For what concern the 95 proteins
present in D27 and absent in Symb1, are worth mentioning the
hemolysin (OG1RF_10438) and the penicillin-binding protein
1B (OG1RF_11450) (Table S1).
D27 and Symb1 share 344 extracellular proteins that
represent about the 90% of the identified proteins. The Voronoi
treemap (Figure 2B) provides an overview of the differentially
expressed proteins between the two strains according to
the quantitative data [based on the normalized spectrum
abundance factors (NSAF)]. As suggested by the graphic
visualization, most of the common proteins show a comparable
level in two strains considered. Forty proteins are more
abundant in D27 as compared Symb1, showing fold changes
ranging between 5.63 and 2.05, most belonging to membrane
transporters and cell-wall biosynthetic enzymes. The proteins
present in D27 and absent in Symb1 are 95, where the
gelatinase (OG1RF_11526) is the most interesting identified
protein (Table S3).
Comparison Food/Pathogen
The cytosolic identified proteins shared by the dairy-isolate
D27 and the clinical isolate UW3114 are 769, corresponding
to the 87% of the total identified proteins (Table S2). As
noticed previously, comparing D27 and Symb1, most of the
proteins were assigned to the functional groups of metabolism-
involved, cell envelope, information storage/processing and
poorly characterized proteins (Figure 3A). The proteins more
abundant in D27, as compared to UW3114, are 43 (Table S2)
and among them the aldehyde-alcohol dehydrogenase (9.47 fold
change - OG1RF_10627), phosphoglycerate mutase (5.50 fold
change - OG1RF_12264), formate acetyltransferase (5.30 fold
change - OG1RF_11329), 2-dehydropantoate 2-reductase (5.20
fold change - OG1RF_11367), uracil phosphoribosyltransferase
(5.14 fold change - OG1RF_11432) show the highest fold change
values. For what concern the 120 proteins present in D27 and
absent in UW3114, are worth mentioning the hemolysin A
(OG1RF_10716) and the β-lactamase (OG1RF_11969).
In the extracellular compartment of the D27 and UW3114,
226 proteins expressed by both strains were found (Table S4).
The Voronoi treemap (Figure 3B) outlines how most of
the proteins (red cells) are more abundant in the food
isolate compared to the clinical strain. In particular, 116
proteins were more abundant in D27 compared to UW3114,
showing fold change ranging between 21.06 and 2.01
(Table S4). Besides membrane transporters and cell-wall
biosynthetic enzymes are worth mentioning a penicillin-
binding protein C (13.75 fold-change - OG1RF_10724)
and a β-lactamase (6.98 fold-change - OG1RF_11219).
The different protein profiles between strains, indicated by
the high fold change variation of the common proteins,
is also supported by the presence of 212 proteins only
identified in D27 and absent in UW3114 (Table S4).
Among these, the most interesting are: choloylglycine
hydrolase (AAM75246.1_39), efflux transporter (RND family
- OG1RF_10301), PFL4705 family integrating conjugative
element protein (OG1RF_12168) and chitin-binding protein
(OG1RF_12499) (Table S4).
Phenotypic Tests
Evaluation of Enzymatic Activities Related to
Pathogenicity
Protease and hemolysis were evaluated in the three strains in
study, being the most common enzymatic activities associated
to virulence, and the results are reported in Figure 4. As
shown in Figure 4A, the strain UW3114 displays a 2-fold
more intense protease activity than the food-isolate D27. As
respect to the probiotic, no comparison can be done since
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FIGURE 1 | Voronoi treemap visualization of cytosolic proteins of E. faecalis D27 (A), E. faecalis Symbioflor 1 (B) and E. faecalis UW3114 (C). Each protein is
represented by a small cell, proteins are clustered according to their functional classification, cell-size correlates with protein abundance. (D) Represents functional
organization of proteins.
for the latter measured absorbance values were negative.
Concerning hemolysis, only the clinical isolate UW3114 shows
hemolytic activity, against horse blood cells, where a β-hemolysis
pattern (formation of clear halos) was observed (Figure 4B).
Concerning gelatinase all the three strains were negative
(data not shown).
Biofilm Formation
The ability to produce extracellular matrix was evaluated by
growing bacteria on an abiotic solid surface, to allow biofilm
formation. Although the three strains were able to secrete
extracellular polymeric substances, biofilm quantification (using
crystal violet staining) demonstrated that for the clinical strain
biofilm is 8-fold more abundant than for Symb1 and 4-fold more
than for D27 (Figure 5).
Antibiotic-Resistance Profiles
To get general insights in the antibiotics susceptibilities and
resistances of the analyzed E. faecalis strains, 18 different
antibiotics were tested and the results reported in Table 1.
All the three isolates showed species-specific resistance to
mupirocin (MUP) and also to clindamycin (CLI). These
results were expected in enterococci, and confirmed by
the test on the reference strain E. faecalis ATCC29212.
None of the isolates showed resistance to glycopeptide
compounds (vancomycin and teicoplanin) or to penicillin
antibiotics (penicillin and ampicillin). Both the probiotic
and the dairy-isolated strain D27 showed to be susceptible
to 16 analyzed antibiotics. Conversely, the clinical isolate
UW3114 was found to be resistant to 8 antibiotics, among
which erythromycin. Erythromycin-resistance is ascribable
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FIGURE 2 | Voronoi treemap visualization depicting the different protein pattern of E. faecalis D27 and E. faecalis Symbioflor 1 in the cytosolic (A) and extracellular (B)
compartment. The proteins are grouped according to their predicted functional classification. Variation of relative protein amounts are indicated by color: red indicates
higher amount in D27, blue higher abundance in Symbioflor 1.
FIGURE 3 | Voronoi treemap visualization depicting the different protein pattern of E. faecalis D27 and E. faecalis UW3114 in the cytosolic (A) and extracellular (B)
compartment. The proteins are grouped according to their predicted functional classification. Variation of relative protein amounts are indicated by color: red indicates
higher amount in D27, blue higher abundance in UW3114.
to the presence of the PAI, as described before by Laverde
Gomez (35).
DISCUSSION
Establishing the safety of a food-isolated strain is of primary
importance especially when the controversial species E. faecalis
is concerned. Actually, enterococci are not generally regarded as
safe (GRAS) by e.g., the FDA. Proteomics is a valuable strategy
to detect virulence characters. Furthermore, comparison with
clearly recognized pathogenic and probiotic bacteria is an added
value to highlight differences useful to classify the food-isolated
strains as safe.
The E. faecalis in study D27 was compared to a clinical isolate
UW3114 and to a commercialized probiotic Symb1. Several
proteins display a significant fold-change as compared to the
other two enterococci or are exclusively present in the food
isolate. Of these, some are worth discussion because of their
implication in pathogenicity, antibiotic resistance, gene transfer
and possible human-host interaction.
Proteins Involved (or Possibly Involved) in
Pathogenicity
Several proteins connected with pathogenic traits are expressed
by the dairy-isolate D27. The protein named “secreted antigen”
was found to be a serine protease by database search (BLAST
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FIGURE 4 | (A) proteolytic activity, measured as optical density (OD) at 440 nm, in E. faecalis D27 and E. faecalis UW3114; (B) hemolytic activity of E. faecalis
UW3114, Symbioflor 1 and D27 tested on horse blood agar plates. Only E. faecalis UW3114 shows β-hemolytic activity.
FIGURE 5 | biofilm quantification after crystal violet staining. The amount of
biofilm produced by E. faecalis D27, E. faecalis Symbioflor 1, and E. faecalis
UW3114 is proportional to the ratio between the crystal violet OD value (595)
and culture OD value (600).
comparison with E. faecalis strains). The serine protease HtrA
(OG1RF_12305) was expressed by both D27 and UW3114,
however it was 2-fold more abundant in the clinical isolate. In the
secretome, a different serine protease SprE (OG1RF_11525) was
detected only in the hospital-isolated strain UW3114. Although
D27 does not express SprE, another serine protease with
pathogenic implications was found, the S41A family carboxy-
terminal peptidase (OG1RF_11392). It has been reported that, in
a murine sepsis model, disease caused by a S41-deficient mutant
of S. aureuswas less severe than that caused by theWT strain; this
result demonstrates the role of these proteins in Gram-positive
pathogenicity (47). A further proteolytic enzyme found in both
D27 and UW3114 secretome is gelatinase (OG1RF_11526), one
among the most important virulence factors in E. faecalis. The
presence of genes for gelatinase E (GelE) and serine protease
V8 (SprE) is usually considered a marker to identify potential
pathogenic strains (48). However, it was already observed that
a cheese-isolated E. faecalis strain does not show gelatinase or
protease activity when submitted to phenotypic tests, even if
possessing the abovementioned genes (16). This phenomenon
was also observed in strains D27 and UW3114, where the
presence of gelatinase enzyme does not support gelatinase
activity. Two different types of hemolysins were present:
hemolysin (OG1RF_10438) and hemolysin A (OG1RF_10716).
D27 expresses both enzymes, whereas both the probiotic and the
clinical strains express only one of them. However, the clinical
isolate is the only strain showing β-hemolysis in vitro, as expected
(Figure 4B). Actually, it is long time established that the presence
of the cyl operon is indispensable but not sufficient for the
hemolytic activity, since different enzymes are involved and a
proteolytic cleavage is required for protein activation (49). The
influence of environmental factors on gene expression is a well-
known phenomenon. For Enterococcus, the effect of multiple
external factors on pathogenic character expression has been
described since 1998 (50).
Finally, a LemA family protein (OG1RF_10353) was found in
D27 and UW3114, with less than 2-fold change in abundance.
This protein family was well characterized in the Pseudomonas
genus, where it was identified as a transmembrane histidine
protein kinase (HPK) sensor-regulators, involved in lesion
formation in the host (51).
Proteins Involved in Antibiotic Resistance
As a general rule, it has to be highlighted that in Enterococci,
antibiotic resistance is based upon three main mechanisms: (a)
intrinsic or natural resistance (b) acquired resistance and (c)
tolerance. The intrinsic resistance is a genus-related feature and
it is generally linked to insensitivity of the bacterial cell to
the antibiotic molecules either through absence of the uptake
mechanism (5), or to a modification of the antibiotic targets such
as the PBPs (penicillin binding proteins) (52) or to efflux systems
(53). Discovered in the 1980 (54) and referred to also as “intrinsic
insensitivity” it is the main cause of the difficulty of treating
enterococcal infections (55). The acquired resistance, on the
contrary, is often based upon production of enzymes modifying
or degrading the antibacterial molecule and it is transmissible
by genetic recombination. Hence, this last mechanism is more
dangerous since it can allow spread of the resistance character
among strains (5).
Two classes of proteins were found that could confer antibiotic
resistance to the E. faecalis strains under investigation: the
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TABLE 1 | Antibiotic susceptibility (green) and resistance (red) of the three tested
strains of E. faecalis, D27, UW3114, and Symbioflor 1, and the quality control
strain E. faecalis ATCC29212, as recommended by EUCAST guidelines.
D27 UW3114 Symbioflor1 ATCC29212
PEN 2 8 4 2
AMP 2 4 4 2
GEN ≤64 512 ≤64 ≤64
STR ≤128 2,048 ≤128 ≤128
VAN 2 2 4 4
TPL ≤1 ≤1 ≤1 ≤1
DAP ≤2 ≤2 ≤2 ≤2
CLI >8 >8 8 8
ERY ≤1 >16 ≤1 ≤1
CIP ≤2 32 ≤2 ≤2
MFL ≤0.125 >2 ≤0.125 0.25
LNZ ≤2 ≤2 ≤2 ≤2
TET ≤0.5 >16 ≤0.5 >16
TGC ≤0.063 ≤0.063 ≤0.063 ≤0.063
RAM 2 ≤1 4 ≤1
SXT ≤0.032 ≤0.032 ≤0.032 ≤0.032
CMP 8 8 8 8
MUP >32 >32 >32 >32
PEN, penicillin; AMP, ampicillin; GEN, gentamycin; STR, streptomycin; VAN, vancomycin;
TPL, teicoplanin; DAP, daptomycin; CLI, clindamycin; ERY, erythromycin; CIP,
ciprofloxacin; MFL, moxifloxacin; LNZ, linezolid; TET, tetracycline; TGC, tigecycline; RAM,
rifampicin; SXT, trimethoprim/sulfamethoxazole; CMP, chloramphenicol; MUP, mupirocin.
true resistance marker β-lactamase and the penicillin-binding
proteins (PBPs) that can be involved in resistance if a mutation
in their sequence occurs. The three strains show to possess a
heterogeneous set of these proteins.
As far as the membrane-located PBPs are concerned, their
relative abundance evaluation has the limitation of a low
reliability, because the extraction procedure could not have
been homogeneous in the three samples analyzed. PBPs (e.g.,
PBP2B, PBP3, PBP4, PBP5) are involved in the peptidoglycan
formation. However, it was observed that the presence of a
high molecular weight variant of PBP5 decreased susceptibility
of E. faecium to ampicillin and other β-lactams (56, 57). In
E. faecalis, resistance to both imipenem and ampicillin due to
amino acid mutation (520 and 605 residues) in the PBP4 was
observed (58). In the cytosolic proteome of the studied strains,
the PBP1A (OG1RF_10925) seems 2.5-fold more abundant
in D27 compared to Symb1; the PBP1B (OG1RF_11450) is
exclusively expressed by D27; the PBPC (OG1RF_10724) was
found in large amount in D27, compared to the other two
strains. Furthermore, extracellular proteins identification in
the food strain confirmed the presence of PBPs, with some
differences respect the cytosolic compartment. PBP1A that in
the cytosol was found more abundant in D27 compared to
Symb1, in the extracellular compartment appears to be more
abundant in the probiotic strain. Therefore, it seems that this
abundance is rather due to compartmentalization than to higher
gene expression.
Three different β-lactamases were found, both in the
intra- and extra-cellular proteomes. Two of them are
metallo-hydrolases, one exclusively expressed in Symb1
(OG1RF_10969) and the other (OG1RF_11863) 2.5-fold
more abundant in the clinical isolate compared to the
food-isolate; the last is a serine-hydrolase (OG1RF_11969)
exclusively expressed in D27. The antibiotic inactivation
based on hydrolytic activity is mostly effective when applied
to β-lactam antibiotics. In particular, there are two main
molecular strategies employed by β-lactamases to hydrolytically
cleave the β-lactam ring of penicillins and cephalosporins:
through the action of an active site Ser-nucleophile, or
through activation of water via a Zn2+ center (59). As
reported in the literature, the proteins described above
are responsible for insensitivity to β-lactam antibiotics in
enterococci (60). Furthermore, this type of resistance seems to
be transmissible (5).
The identification of a high variety of proteins, possibly
involved in resistance, found in the proteomes of the three
strains in study, suggests that resistance events could occur
also in the probiotic and the dairy-isolate that share a similar
antibiotitype. Actually, probiotics were already described as
harboring resistance traits (61). However, in spite of these protein
profiles, the antibiotic susceptibility testing revealed a general
sensitivity pattern toward beta-lactams in all the three strains
considered (Table 1). As far as the PBPs are concerned, it is
possible that they are active and not mutated forms as those
described in E faecalis by Ono (58). Regarding beta lactamases,
it is possible to hypothesize that the expression of these proteins
is a condition necessary but not sufficient to engender resistance,
suggesting that other factors can play a role in the occurrence of
resistant phenotypes.
As far as the food-borne Enterococcus D27 is concerned, an
efflux transporter (RND family - OG1RF_10301) has also been
found. Efflux pumps, responsible either of multidrug resistance
mechanisms or of single antibiotic extrusion, have been described
in LAB as well (62). In the strain D27 this efflux system could
be involved in the clindamycin resistance pattern observed
(Table 1), whereas the resistance to mupirocin observed seems
to be due to other mechanisms as it has long been established
(63). On the other hand, both these resistances are present in
all the three strain considered, suggesting that they can be based
upon an intrinsic resistance mechanism as frequently described
for Enterococci (55).
Proteins Involved in Horizontal Gene
Transfer
The PFL4705 family integrating conjugative element protein
(OG1RF_12168) was found both in the food-isolate D27 and
in the probiotic strain Symb1, with comparable expression
levels. Often, virulence determinants are acquired as mobile
elements during gene transfer processes also mediated by this
protein and these genetic exchanges are frequent between E.
faecalis strains (35, 64).The second interesting protein more
expressed by D27, is the pheromone cAM373 (OG1RF_11130).
It was characterized also in S. aureus and corresponds to a
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heptapeptide (AIFILAS) located within the C-termini of the
signal sequences of putative pre-lipoproteins. This hydrophobic,
linear peptide molecule acts as signals that facilitate the
conjugative transfer of a specific category of plasmids referred
to as pheromone-responsive plasmids (65). This specific type
of inducible plasmid represents an important mechanism for
dissemination of antibiotic resistance and virulence among
Enterococcus strains (66). These findings also suggest that the
food ecosystem is a suitable environment for favoring cell-to-
cell communication.
In the extracellular fraction, a second pheromone, cAD1
(OG1RF_12509), more expressed by the dairy-isolate, was found.
In E. faecalis, this octapeptide sex pheromone was identified as
responsible of an induced mating response by donors carrying
the hemolysin plasmid pAD1 or related elements (67). This
result, although expected for the clinical isolate is surprising for
the food strain that generally do not need to acquire hemolysins
in its ecological niche.
Proteins Involved in Human
Host/Environment Interactions
The von Willebrand factor (vWF) type A domain protein
(OG1RF_10869) is an example of potential pathogenicity-
associated protein more expressed in the secretome by the food-
isolate strain compared to the probiotic and clinical isolates (fold-
change 2.21 and 2.16, respectively). vWF is a huge multimeric
protein, well-characterized in humans, where it triggers platelet
adhesion in areas of vascular damage. In particular, the domain
A1 mediates platelet adhesion under flow in areas of vessel
injury through the platelet glycoprotein Ibα (GPIbα) (68). Most
prokaryotic vWF domains have not been investigated in detail,
however, Konto-Ghiorghi et al. (69) showed that the GBS
PilA tip pilin vWF domain was important for pilus-mediated
bacterial adhesion to human alveolar and intestinal epithelial
cells in vitro. The last newsworthy evidence is the variety of
lipoproteins produced by the dairy-isolate. Even if the function
and the localization is still unknown for most of them it is well-
recognized that lipoproteins in Gram-positive bacteria represent
about the 25% of the surface associated proteins, which could play
a major role in bacterial virulence processes (70).
Among up-regulated proteins in D27, choloylglycine
hydrolase (AAM75246.1_39) represents an interesting enzyme
since it catalyzes the initial “gateway” reaction in the bacterial
metabolism of CBAs (conjugated bile acids). The reaction
consists in a deconjugation of CBAs to liberate free primary bile
acids (BAs; cholic acid or chenodeoxycholic acid) and amino
acids (71). CBAs have been suggested to repress bacterial growth
in the small intestine by means of direct antimicrobial effects,
up-regulation of host mucosal defenses, or synergistic action of
both mechanisms (72). The expression of this enzyme by the
food-isolate can increase the ability of the strain to survive to
CBAs action in the gut, thus enhancing the probiotic potential
of D27. This is partly expected, because Enterococci generally
display a high degree of resistance to bile salts (73). Considering
that, all the three strains share the presence of several proteins
involved in mucosa and mucus adhesion (e.g., enolase, EFTu,
EFTs, DnaK, Clp, GroEL, chitin-binding protein) (74, 75), it is
possible to hypothesize that the foodborne D27 can also share
the same attitude to persist in the human host by adhering to
the gut mucosa. However, D27 ability to form biofilm, although
higher than Symb1, is four-fold lower than the one observed in
the pathogenic UW3114.
CONCLUSION
The results obtained in the present investigation comparing
a food-isolated E. faecalis D27 with a patented probiotic
and a pathogenic isolate, underline that there is the need
of a detailed typing of strains, either employed in food
fermentation or foodborne contaminants, to avoid risks of
virulence dissemination.
The probiotic strain E. faecalis Symbioflor 1, although bearing
some resistance traits, possess several proteins that support its
role as a probiotic, namely involved in stress response, that are
of primary importance both for the shelf-life of the probiotic
preparation and for bacterial survival in the human gastro-
intestinal tract. The clinical isolate E. faecalis UW3114 was
the only strain synthesizing some of the ascertained virulence
determinants such as the serine protease SprE and displaying the
highest levels of antibiotic resistance included aminoglycosides.
All these results were expected.
As far as the foodborne isolate is concerned, E. faecalis
D27 besides showing a high metabolic activity (confirmed by
the up-regulation of several proteins involved in hydrolysis,
energy metabolism, and nutrient transport) also displays some
proteins whose function could be hazardous. Among these,
antibiotic resistance factors (although not all expressed in the
tested conditions) and horizontal gene transfer involved proteins
(PFL4705 family integrating conjugative element), are a clear
evidence that recombination events (both in food and in the GIT)
can cause antibiotic resistance spread. Other possible virulence
factors are the vWF type A domain protein, and some proteases
involved in pathogenicity, like the serine protease HtrA, the S41A
family carboxy-terminal peptidase and LemA.On the other hand,
the presence in D27 of a high number of proteolytic enzymes
is probably linked to the advantage of possessing proteases in
a food matrix like cheese that is very rich in proteins. It is
worth to highlight that single approaches for typing bacteria to
find pathogenicity factors all have the limitation of considering
characters (genes or proteins) that not always are disclosed.
Considering the heterogeneous habitat in which food
microorganisms live, modifications of their proteomic patterns
can also occur both by interaction with other bacteria (genetic
exchanges) and during contact with the host. The results obtained
in the present investigation are far to be exhaustive since new
genes and proteins involved in pathogenesis in different E.
faecalis strains are repeatedly reported in the literature. However,
taken together, these data demonstrate the importance of
carefully and periodically characterize food-isolated enterococcal
strains to ascertain their safety before employing them for
human consumption. In this context, in parallel to genetic
analysis, complementing gel-free proteomics (especially the
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analyses concerning secreted “marker-factors”) and phenotypic
tests proved to be a valuable tool to assess these features.
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Table S1 | The table includes the cytosolic proteins identified in at least two of the
three biological replicates of E. faecalis D27 and E. faecalis Symbioflor 1 and the
proteins found only in one E. faecalis strain and absent (off) in the other strain. The
fold-change is given by the ratio between the average of the protein abundance
(fmol/ng) in E. faecalis D27 and the average of the protein abundance (fmol/ng) in
E. faecalis Symbioflor 1. Accession, protein name, description, localization
(obtained by pSortb), main role and subrole are reported to give information on the
protein function. For each protein, the abundance (fmol/ng) for all the biological
replicates, as well as the average of the abundance are reported for both E.
faecalis D27 and E. faecalis Symbioflor 1. The Repcount refers to the number of
technical replicates in which the protein was identified.
Table S2 | The table includes the cytosolic proteins identified in at least two of the
three biological replicates of E. faecalis D27 and E. faecalis UW3114 and the
proteins found only in one E. faecalis strain and absent (off) in the other strain. The
fold-change is given by the ratio between the average of the relative abundance
(fmol/ng) in E. faecalis D27 and the average of the relative abundance (fmol/ng) in
E. faecalis UW3114. Accession, protein name, description, localization (obtained
by pSortb), main role and subrole are reported to give information on the protein
function. For each protein, the abundance (fmol/ng) for all the biological replicates,
as well as the average of the abundance are reported for both E. faecalis D27 and
E. faecalis UW3114. The Repcount refers to the number of technical replicates in
which the protein was identified.
Table S3 | The table includes the secreted proteins identified in at least two of the
three biological replicates of E. faecalis D27 and E. faecalis Symbioflor 1 and the
proteins found only in one E. faecalis strain and absent (off) in the other strain. The
fold-change is given by the ratio between the average of the abundance
[normalized spectral abundance factor (NSAF)] in E. faecalis D27 and the average
of the abundance (NSAF) in E. faecalis Symbioflor 1. Accession, protein name,
description, localization (obtained by pSortb), main role and subrole are reported
to give information on the protein function. For each protein, the abundance
(NSAF) for all the biological replicates are reported for both E. faecalis D27 and E.
faecalis Symbioflor 1.
Table S4 | The table includes the secreted proteins identified in at least two of the
three biological replicates of E. faecalis D27 and E. faecalis UW3114 and the
proteins found only in one of E. faecalis strain and absent (off) in the other strain.
The fold-change is given by the ratio between the average of the abundance
[normalized spectral abundance factor (NSAF)] in E. faecalis D27 and the average
of the abundance (NSAF) in E. faecalis UW3114. Accession, protein name,
description, localization (obtained by pSortb), main role and subrole are reported
to give information on the protein function. For each protein, the abundance
(NSAF) for all the biological replicates are reported for both E. faecalis D27 and E.
faecalis UW3114.
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